AtriCure, Inc.
ATRCNasdaqCIK 1323885HealthcareFiscal year ends Dec 31
Reports and events: 263 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-2713:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001323885-26-000035 |
| 2026-07-2316:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000032 |
| 2026-05-1916:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001323885-26-000025 |
| 2026-05-0612:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001323885-26-000023 |
| 2026-05-0621:01 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000020 |
| 2026-05-0516:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000018 |
| 2026-04-0611:54 ET | DEF 14A | Proxy statementPeriod 2026-04-06 | 0001323885-26-000010 |
| 2026-02-1912:39 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001323885-26-000007 |
| 2026-02-1716:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-26-000005 |
| 2026-01-1208:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-009814 |
| 2025-10-3012:21 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001323885-25-000103 |
| 2025-10-2917:18 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000101 |
| 2025-10-2916:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000098 |
| 2025-07-3012:34 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001323885-25-000095 |
| 2025-07-2916:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000092 |
| 2025-05-2016:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001323885-25-000050 |
| 2025-04-3013:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001323885-25-000043 |
| 2025-04-2916:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000041 |
| 2025-04-0716:03 ET | DEF 14A | Proxy statementPeriod 2025-04-07 | 0001323885-25-000037 |
| 2025-03-2613:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001323885-25-000033 |
| 2025-02-1413:39 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001323885-25-000009 |
| 2025-02-1216:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-25-000005 |
| 2025-01-1308:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001323885-25-000002 |
| 2024-10-3011:49 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001323885-24-000117 |
| 2024-10-2916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000115 |
| 2024-07-3111:39 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001323885-24-000106 |
| 2024-07-3016:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000104 |
| 2024-05-1416:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001323885-24-000068 |
| 2024-05-0211:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001323885-24-000062 |
| 2024-05-0116:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000060 |
| 2024-04-0317:05 ET | DEF 14A | Proxy statementPeriod 2024-04-03 | 0001323885-24-000055 |
| 2024-02-2708:50 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001323885-24-000020 |
| 2024-02-1614:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001323885-24-000016 |
| 2024-02-1516:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-24-000013 |
| 2024-01-0808:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-003922 |
| 2024-01-0408:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001323885-24-000004 |
| 2023-11-0212:17 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001323885-23-000110 |
| 2023-11-0116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000107 |
| 2023-07-2613:42 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001323885-23-000097 |
| 2023-07-2516:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000094 |
| 2023-05-2611:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001323885-23-000053 |
| 2023-05-0312:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001323885-23-000047 |
| 2023-05-0216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000045 |
| 2023-04-1015:17 ET | DEF 14A | Proxy statement | 0001323885-23-000039 |
| 2023-02-2213:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001323885-23-000015 |
| 2023-02-2116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-23-000012 |
| 2023-01-0908:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001323885-23-000008 |
| 2022-11-0213:56 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001323885-22-000116 |
| 2022-11-0116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001323885-22-000113 |
| 2022-08-0314:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001323885-22-000101 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:40 ET. Listed shows no prices and gives no investment advice.